• 学术搜索
  • 科研智能体
    • Research Labs
    • AI 阅读
    • AI 文库
    • 深度研究
    • 学者亮点
  • 学术资源
    • AI2000
    • 期刊/会议
    • 学者库
    • 学术API
      MCP&Skill
    • 溯源树
    • 数据集
  • 知识沉淀
    • 学术空间
订阅小程序
旧版功能
aminer vip
开通会员低至0.73元/天
一次搞定AI科研
立即登录
  • English
  • 联系方式
    Gynecologic and obstetric investigation

    Gynecologic and obstetric investigation

    JournalISSN 0378-7346eISSN 1423-002X中科院 医学 4区

    年发文量

    研究主题

    论文(20704)

    排序
    1Effect of the Interval Between Consecutive Treatment Cycles on Outcomes of Elective Oocyte Cryopreservation
    Yuval Kuchuk,Netanella Miller,Roni Rahav-Koren, May Weinberg,Mattan Levi,Amir Wiser,Einat Haikin Herzberger

    Abstract Purpose: To assess whether the interval length between consecutive elective oocyte cryopreservation cycles influences ovarian response and oocyte yield. Methods: This retrospective cohort study included 138 fertility preservation patients who underwent multiple treatment cycles for social indications.. Only patients with at least two treatment cycles were included in the analysis. The interval length between two treatment cycles was obtained and medical charts were reviewed for demographic information and treatment outcomes. The main Outcome Measures were the number and rate of mature oocyte. Results: Treatment outcomes were comparable across short- and long-interval groups. The mean number of mature oocytes retrieved was 6.6 ± 4.0 in the short-interval group and 8.3 ± 5.0 in the long-interval group (p = 0.115). Maturation rates were similar (74% vs. 77%; p = 0.481). Cycle-to-cycle changes in oocyte yield were minimal in the short vs. long-interval groups, respectively: Δ total oocytes: –0.6 ± 4.8 vs. –0.2 ± 4.8; p = 0.714) and Δ maturation rates (–9% ± 44% vs. +5% ± 46%; p = 0.211). Conclusions: Interval duration between consecutive oocyte cryopreservation cycles does not significantly affect oocyte yield or maturation rate. These findings suggest that clinicians may schedule subsequent cycles according to patient preferences and practical considerations rather than physiological constraints.

    2026
    引用
    AI阅读
    加入学术空间
    2MRI-Based Analysis of Post-HIFU Efficacy in Uterine Adenomyosis and Personalized Treatment Strategies
    Yan Chen,Fangfang zhang, Hong Wu,Yanlin Wang, Yang He,Honggui Zhou, Jing Jiang

    Abstract Objectives To evaluate the clinical outcomes of high-intensity focused ultrasound (HIFU) ablation in patients with different subtypes of adenomyosis as classified by preoperative magnetic resonance imaging (MRI), and to explore the implications for personalized treatment planning. Design A retrospective cohort study. Participants 447 patients with adenomyosis who underwent HIFU treatment were classified according to the Kishi MRI criteria into Type I (intrinsic, n=195), Type II (extrinsic, n=92), Type III (intramural, n=50), and Type IV (full-thickness, n=110). Methods All 447 patients underwent HIFU ablation under standardized procedural protocols.Treatment parameters, non-perfused volume (NPV) ratio, relief of dysmenorrhea (assessed by NRS score), and improvement in menstrual blood volume (assessed by FPS score) were analyzed and compared across subtypes at 3 and 6 months post-treatment. Results Patients with Type IV adenomyosis had significantly larger lesion volumes and required longer treatment durations with higher energy delivery (p<0.001). The NPV ratio was highest in Type I (74.91% ± 28.34%), followed by Type III (70.34% ± 26.12%), both significantly higher than in Type II (60.01% ± 2.9%) and Type IV (65.93% ± 25.41%) (p<0.05). All subtypes demonstrated significant and sustained improvement in both dysmenorrhea and menorrhagia at follow-up (p<0.05). The comprehensive treatment success rate was highest for Type IV at both 3 (21.82%) and 6 months (27.27%). Limitations This study has several limitations. First, the retrospective design inherently introduces selection bias and limits causal inference. Second,long-term follow-up beyond 6 months was not available, precluding assessment of durability of symptom relief and recurrence rates. Conclusions High-intensity focused ultrasound (HIFU) provides effective symptom relief for all MRI-classified subtypes of adenomyosis. Treatment parameters and efficacy, however, vary by subtype. MRI classification is therefore crucial for guiding treatment and anticipating technical challenges. A personalized approach based on subtype may further optimize therapeutic outcomes.

    2026
    引用
    AI阅读
    加入学术空间
    3Cost-Consequence Analysis Comparing Originator R-Hfsh-alfa and Biosimilars for =4 Complete Ovarian Stimulation Cycles During Assisted Reproductive Technology Treatment: A Multi-Country Perspective
    Claudia Roeder,Roberta Longo, Jeroen Luyten,Juan-Enrique Schwarze, Kemal Uca,Cristina Masseria, Mackenzie Mills

    Objectives: Assisted reproductive technology (ART) demand is increasing, raising questions about the cost-effectiveness of ovarian stimulation (OS) treatments. This study evaluates the clinical and economic outcomes of originator recombinant human follicle-stimulating hormone (r-hFSH-alfa) compared with its biosimilars across multiple ART cycles and countries. Design: A cost-consequence analysis was conducted using a decision-tree model simulating up to four complete OS cycles in women undergoing ART across seven countries (Spain, France, Germany, the United Kingdom, Denmark, Australia, and South Korea). The analysis incorporated both fresh and frozen embryo transfers within each cycle and included base-case and scenario analyses, including treatment-switching strategies. Participants: Theoretical model corresponding to women undergoing ART and receiving originator r-hFSH-alfa or a biosimilar for OS. Methods: Clinical inputs were derived from published real-world data and a meta-analysis. Economic inputs were estimated from public payer perspectives and included drug acquisition, ART procedures, embryo transfer, pregnancy, and delivery costs. Outcomes included cumulative live birth rate (CLBR), total costs, and cost per LB. Base-case and scenario analyses, including treatment-switching strategies, were conducted alongside deterministic sensitivity analyses. Results: Originator r-hFSH-alfa was associated with a higher CLBR compared with biosimilars (58.2% vs 50.8%). This advantage persisted across scenarios and time horizons. Despite slightly higher drug acquisition costs, originator r-hFSH-alfa resulted in lower cost per LB across all countries, with savings ranging from approximately €2,900 to over €8,000 per LB. Strategies initiating treatment with biosimilars were consistently dominated (less effective and more costly) compared to strategies starting with r-hFSH-alpha. Results were robust to sensitivity analyses, with LB rate differences being the primary driver of outcomes. Limitations: This model included limited national clinical data and reliance on modeled assumptions. Other studies are needed to further establish the robustness of the effectiveness data used here. Indirect societal costs and the emotional burden associated with unsuccessful ART cycles were not included. Additionally, costs related to ovarian hyperstimulation syndrome were excluded because rates are very similar between both treatment arms. Conclusions: Across multiple countries and healthcare systems and based on the available effectiveness evidence, initiating ART with originator r-hFSH-alfa improves clinical outcomes and reduces cost per live birth compared with biosimilars. These findings highlight the importance of evaluating ART strategies based on overall treatment pathway value rather than drug acquisition cost alone and support prioritizing more effective treatments in clinical and reimbursement decision-making.

    2026
    引用
    AI阅读
    加入学术空间
    4Attitudes Toward Using Non-Medical Eligibility Criteria for Publicly Funded IVF: a Population Survey in Belgium
    Astrid Van Muylder,Roselinde Kessels,Thomas D´Hooghe,Jeroen Luyten

    Background: Assisted Reproductive Technologies (ART) such as in-vitro fertilization (IVF) are often reimbursed based on non-medical eligibility criteria, such as patients’ age, marital status, relationship type or reproductive history. These criteria reflect normative assumptions about parenthood and remain ethically contested. Objectives: This study investigates the Belgian public’s awareness of and attitudes toward the use of such non-medical criteria in reimbursing IVF and identifies socio-demographic patterns underlying these views. Methods: A sample of 3,000 adults (18-70y) completed an online survey that elicited attitudes towards public funding of IVF and using funding restrictions based on patients’ age, partner age and gender, relationship type, number of prior children, and different infertility etiologies. Latent class cluster analysis (LCCA) was used to detect opinion subgroups, and logistic regression to assess socio-demographic predictors of subgroup membership. Results: Although there was strong overall support for public reimbursement of IVF, respondents showed limited knowledge about eligibility criteria within the Belgian system. Majorities endorsed several eligibility restrictions, including those based on maternal age (74%), partner age (57%), number of prior biological children (60%), and consciously delayed childbearing (70%). Two thirds opposed prioritizing heterosexual couples. LCCA revealed three distinct opinion profiles (generous, moderately restrictive, and highly restrictive), primarily differentiated by the perceived generosity of current Belgian policy, access for same-sex couples and single mothers, and the acceptability of patient copayments. Parenthood experience and prior infertility were significant predictors of profile membership. Conclusion: This study finds widespread public support for reimbursing fertility treatment within Belgian healthcare, but also for using eligibility criteria that extend beyond the currently used, sole criterion of maternal age. In the light of growing infertility rates, pressured ART budgets and the limited awareness of the current policy observed in this survey, these results underscore the need for further societal debate on priority setting in Belgian infertility care.

    2026
    引用
    AI阅读
    加入学术空间
    5Performance of Large Language Models Combined with Clinical Decision Support for Recurrent Pregnancy Loss Management
    Jing Zhe, Zhounan Zhu,Dan Zheng

    Background: Recurrent pregnancy loss (RPL) affects 1%–5% of women worldwide. Advanced maternal age and increasing pre-pregnancy coexisting diseases have complicated its clinical management. Large language models (LLMs) and clinical decision support (CDS) tools are widely used clinically, yet combined use evidence for RPL remains scarce. Objective: To evaluate whether structured CDS materials improve the guideline compliance of three LLMs for standardized RPL clinical scenarios. Design: Comparative simulation study with self-controlled two-stage assessment. Method: Two reproductive medicine specialists developed 25 standard clinical scenarios based on the 2018 and 2022 ESHRE guidelines. Three LLMs (ChatGPT-5.5, Claude-4.8, DeepSeek-R1) were assessed in two phases: baseline evaluation and assessment with structured CDS figures. Response compliance with guidelines was evaluated. Weighted pooled Cohen’s kappa was used to assess inter-rater reliability. The Friedman test with Bonferroni correction was applied for inter-group comparisons, and the Wilcoxon signed-rank test for paired analyses. Results: At baseline, the full guideline compliance rates of the ChatGPT-5.5, Claude-4.8, and DeepSeek-R1 were 44.0%, 28.0%, and 20.0%, with significant differences among groups (P<0.05). After CDS intervention, the rates increased to 92.0%, 84.0%, and 80.0%. All models showed statistically significant improvements (ChatGPT-5.5: P=0.00033; Claude-4.8: P=8.2×10⁻⁵; DeepSeek-R1: P=2.8×10⁻⁵). Dimension-based analysis revealed that all three models achieved a 100% accuracy rate in judging the definition of RPL throughout the study. With the support of CDS tools, their performance in core items, including key screening, etiological, recommended, and non-recommended interventions, was greatly enhanced. No seriously incorrect responses were observed in the whole process. Limitations: This study only included 25 typical clinical scenarios, which is a relatively small sample. In addition, all CDS reference materials were presented in a single unified table format. Conclusion: LLMs only deliver moderate performance in baseline RPL management and are not competent to replace clinical judgment. Combining LLMs with structured CDS tools can remarkably improve the consistency of their outputs with clinical guidelines. This combination can serve as a reliable auxiliary tool for routine RPL clinical work.

    2026
    引用
    AI阅读
    加入学术空间
    立即登录,查看全部 20704 篇论文

    高被引作者

    作者引用发文
    Aihik Banerjee16271
    Jin Nam16271
    Liqiang Wang103612
    Jincheng Wang91220
    SHAO Zhen8811
    Jiangtao Wu8811
    XiaoJia Bai8811
    Yanping Wang8811
    Jingli Xie8811
    Weitao Geng8811

    高产作者

    作者引用发文
    M.M. de Monchy188
    Fritz Kermauner2364
    Manabu Kitao64463
    Arthur Stein461
    Ernst Puppel2358
    T Hata71556
    Hugo Sellheim2756
    Adolf Theilhaber1056
    Georg Heinrich Schneider150
    J.A. Amann3348

    相关期刊

    Macromolecular Bioscience
    Journal of biological engineering
    Tissue engineering. Part A
    Biomedical materials (Bristol, England)
    Tissue Engineering Part B-Reviews
    Regenerative biomaterials
    Bioengineering & Translational Medicine
    Biomaterials Research
    SLAS Technology
    MATERIALS TODAY BIO